Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Reports Steep Increase in Revenues, Earnings for Q1

NEW YORK, April 28 (GenomeWeb News) - Third Wave Technologies reported a steep increase in revenues and earnings for the first quarter today.

 

Revenues were $15.3 million, up from $8.5 million during the first quarter last year. This was higher than expected, Third Wave said, due to increased demand for genomic research products in Japan, where the government's fiscal year ended at the end of March.

 

Research and development costs for the quarter stayed flat, at $2.9 million.

 

Earnings for the quarter were $2.8 million, or $.07 per share, compared to a loss of $2.9 million, or $.07 per share, during the year-ago period.

 

As of March 31, Third Wave had $59.9 million in cash, cash equivalents, and short-term investments.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.